Literature DB >> 20518019

Human embryonic stem cells are capable of executing G1/S checkpoint activation.

Tomás Bárta1, Vladimír Vinarský, Zuzana Holubcová, Dása Dolezalová, Jan Verner, Sárka Pospísilová, Petr Dvorák, Ales Hampl.   

Abstract

Embryonic stem cells progress very rapidly through the cell cycle, allowing limited time for cell cycle regulatory circuits that typically function in somatic cells. Mechanisms that inhibit cell cycle progression upon DNA damage are of particular importance, as their malfunction may contribute to the genetic instability observed in human embryonic stem cells (hESCs). In this study, we exposed undifferentiated hESCs to DNA-damaging ultraviolet radiation-C range (UVC) light and examined their progression through the G1/S transition. We show that hESCs irradiated in G1 phase undergo cell cycle arrest before DNA synthesis and exhibit decreased cyclin-dependent kinase two (CDK2) activity. We also show that the phosphatase Cdc25A, which directly activates CDK2, is downregulated in irradiated hESCs through the action of the checkpoint kinases Chk1 and/or Chk2. Importantly, the classical effector of the p53-mediated pathway, protein p21, is not a regulator of G1/S progression in hESCs. Taken together, our data demonstrate that cultured undifferentiated hESCs are capable of preventing entry into S-phase by activating the G1/S checkpoint upon damage to their genetic complement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20518019     DOI: 10.1002/stem.451

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  31 in total

Review 1.  Regulation of stem cell plasticity: mechanisms and relevance to tissue biology and cancer.

Authors:  Robert Strauss; Petra Hamerlik; André Lieber; Jiri Bartek
Journal:  Mol Ther       Date:  2012-02-07       Impact factor: 11.454

Review 2.  The retinoblastoma tumor suppressor and stem cell biology.

Authors:  Julien Sage
Journal:  Genes Dev       Date:  2012-07-01       Impact factor: 11.361

Review 3.  Molecular mechanisms controlling the cell cycle in embryonic stem cells.

Authors:  Essam M Abdelalim
Journal:  Stem Cell Rev Rep       Date:  2013-12       Impact factor: 5.739

4.  Human embryonic and induced pluripotent stem cells express TRAIL receptors and can be sensitized to TRAIL-induced apoptosis.

Authors:  Vladimir Vinarsky; Jan Krivanek; Liina Rankel; Zuzana Nahacka; Tomas Barta; Josef Jaros; Ladislav Andera; Ales Hampl
Journal:  Stem Cells Dev       Date:  2013-08-02       Impact factor: 3.272

5.  Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts.

Authors:  Miriama Krutá; Monika Šeneklová; Jan Raška; Anton Salykin; Lenka Zerzánková; Martin Pešl; Eva Bártová; Michal Franek; Aneta Baumeisterová; Stanislava Košková; Kai J Neelsen; Aleš Hampl; Petr Dvořák; Vladimír Rotrekl
Journal:  Stem Cells Dev       Date:  2014-07-25       Impact factor: 3.272

Review 6.  Mechanisms maintaining genomic integrity in embryonic stem cells and induced pluripotent stem cells.

Authors:  Elisia D Tichy
Journal:  Exp Biol Med (Maywood)       Date:  2011-07-18

7.  p53, Stem Cells, and Reprogramming: Tumor Suppression beyond Guarding the Genome.

Authors:  Benjamin T Spike; Geoffrey M Wahl
Journal:  Genes Cancer       Date:  2011-04

8.  Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells.

Authors:  Séverine Cruet-Hennequart; Áine M Prendergast; Georgina Shaw; Frank P Barry; Michael P Carty
Journal:  Int J Hematol       Date:  2012-10-18       Impact factor: 2.490

Review 9.  Pluripotent Stem Cells and DNA Damage Response to Ionizing Radiations.

Authors:  Kalpana Mujoo; E Brian Butler; Raj K Pandita; Clayton R Hunt; Tej K Pandita
Journal:  Radiat Res       Date:  2016-06-22       Impact factor: 2.841

10.  G1 checkpoint is compromised in mouse ESCs due to functional uncoupling of p53-p21Waf1 signaling.

Authors:  Irina I Suvorova; Bogdan B Grigorash; Ilya A Chuykin; Tatiana V Pospelova; Valery A Pospelov
Journal:  Cell Cycle       Date:  2016       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.